123 related articles for article (PubMed ID: 25186130)
1. A design strategy for small molecule-based targeted MRI contrast agents: their application for detection of atherosclerotic plaques.
Iwaki S; Hokamura K; Ogawa M; Takehara Y; Muramatsu Y; Yamane T; Hirabayashi K; Morimoto Y; Hagisawa K; Nakahara K; Mineno T; Terai T; Komatsu T; Ueno T; Tamura K; Adachi Y; Hirata Y; Arita M; Arai H; Umemura K; Nagano T; Hanaoka K
Org Biomol Chem; 2014 Nov; 12(43):8611-8. PubMed ID: 25186130
[TBL] [Abstract][Full Text] [Related]
2. In vivo magnetic resonance imaging of atherosclerotic lesions with a newly developed Evans blue-DTPA-gadolinium contrast medium in apolipoprotein-E-deficient mice.
Yasuda S; Ikuta K; Uwatoku T; Oi K; Abe K; Hyodo F; Yoshimitsu K; Sugimura K; Utsumi H; Katayama Y; Shimokawa H
J Vasc Res; 2008; 45(2):123-8. PubMed ID: 17940339
[TBL] [Abstract][Full Text] [Related]
3. In vivo labeling of B16 melanoma tumor xenograft with a thiol-reactive gadolinium based MRI contrast agent.
Menchise V; Digilio G; Gianolio E; Cittadino E; Catanzaro V; Carrera C; Aime S
Mol Pharm; 2011 Oct; 8(5):1750-6. PubMed ID: 21780833
[TBL] [Abstract][Full Text] [Related]
4. Detection of atherosclerotic plaque with Gadofluorine-enhanced magnetic resonance imaging.
Barkhausen J; Ebert W; Heyer C; Debatin JF; Weinmann HJ
Circulation; 2003 Aug; 108(5):605-9. PubMed ID: 12835227
[TBL] [Abstract][Full Text] [Related]
5. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.
Ouimet T; Lancelot E; Hyafil F; Rienzo M; Deux F; Lemaître M; Duquesnoy S; Garot J; Roques BP; Michel JB; Corot C; Ballet S
Mol Pharm; 2012 Apr; 9(4):850-61. PubMed ID: 22352457
[TBL] [Abstract][Full Text] [Related]
6. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
7. Contrast enhancement by differently sized paramagnetic MRI contrast agents in mice with two phenotypes of atherosclerotic plaque.
van Bochove GS; Paulis LE; Segers D; Mulder WJ; Krams R; Nicolay K; Strijkers GJ
Contrast Media Mol Imaging; 2011; 6(1):35-45. PubMed ID: 20882509
[TBL] [Abstract][Full Text] [Related]
8. Contrast enhancement by lipid-based MRI contrast agents in mouse atherosclerotic plaques; a longitudinal study.
den Adel B; van der Graaf LM; Que I; Strijkers GJ; Löwik CW; Poelmann RE; van der Weerd L
Contrast Media Mol Imaging; 2013; 8(1):63-71. PubMed ID: 23109394
[TBL] [Abstract][Full Text] [Related]
9. MRI study of atherosclerotic plaque progression using ultrasmall superparamagnetic iron oxide in Watanabe heritable hyperlipidemic rabbits.
Kaneko C; Nitta N; Tsuchiya K; Watanabe S; Nitta-Seko A; Ohta S; Otani H; Sonoda A; Murata K; Shiomi M
Br J Radiol; 2015 Sep; 88(1053):20150167. PubMed ID: 26083261
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Magnetic Resonance Imaging of Atherosclerosis in Apolipoprotein E Knockout Mouse Model Using Macrophage-Targeted Gadolinium-Containing Synthetic Lipopeptide Nanoparticles.
Shen ZT; Zheng S; Gounis MJ; Sigalov AB
PLoS One; 2015; 10(11):e0143453. PubMed ID: 26569115
[TBL] [Abstract][Full Text] [Related]
11. Method for enhancing cell penetration of Gd3+-based MRI contrast agents by conjugation with hydrophobic fluorescent dyes.
Yamane T; Hanaoka K; Muramatsu Y; Tamura K; Adachi Y; Miyashita Y; Hirata Y; Nagano T
Bioconjug Chem; 2011 Nov; 22(11):2227-36. PubMed ID: 21985057
[TBL] [Abstract][Full Text] [Related]
12. Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA.
Burtea C; Laurent S; Murariu O; Rattat D; Toubeau G; Verbruggen A; Vansthertem D; Vander Elst L; Muller RN
Cardiovasc Res; 2008 Apr; 78(1):148-57. PubMed ID: 18174291
[TBL] [Abstract][Full Text] [Related]
13. The time window of MRI of murine atherosclerotic plaques after administration of CB2 receptor targeted micelles: inter-scan variability and relation between plaque signal intensity increase and gadolinium content of inversion recovery prepared versus non-prepared fast spin echo.
te Boekhorst BC; Bovens SM; van de Kolk CW; Cramer MJ; Doevendans PA; ten Hove M; van der Weerd L; Poelmann R; Strijkers GJ; Pasterkamp G; van Echteld CJ
NMR Biomed; 2010 Oct; 23(8):939-51. PubMed ID: 20878972
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach.
Lancelot E; Amirbekian V; Brigger I; Raynaud JS; Ballet S; David C; Rousseaux O; Le Greneur S; Port M; Lijnen HR; Bruneval P; Michel JB; Ouimet T; Roques B; Amirbekian S; Hyafil F; Vucic E; Aguinaldo JG; Corot C; Fayad ZA
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):425-32. PubMed ID: 18258820
[TBL] [Abstract][Full Text] [Related]
15. Peptidic targeting of phosphatidylserine for the MRI detection of apoptosis in atherosclerotic plaques.
Burtea C; Laurent S; Lancelot E; Ballet S; Murariu O; Rousseaux O; Port M; Vander Elst L; Corot C; Muller RN
Mol Pharm; 2009; 6(6):1903-19. PubMed ID: 19743879
[TBL] [Abstract][Full Text] [Related]
16. Annexin A5-functionalized bimodal nanoparticles for MRI and fluorescence imaging of atherosclerotic plaques.
van Tilborg GA; Vucic E; Strijkers GJ; Cormode DP; Mani V; Skajaa T; Reutelingsperger CP; Fayad ZA; Mulder WJ; Nicolay K
Bioconjug Chem; 2010 Oct; 21(10):1794-803. PubMed ID: 20804153
[TBL] [Abstract][Full Text] [Related]
17. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of calcium responsive magnetic resonance imaging agent: Its relaxation and luminescence studies.
Tanwar J; Datta A; Chauhan K; Kumaran SS; Tiwari AK; Kadiyala KG; Pal S; Thirumal M; Mishra AK
Eur J Med Chem; 2014 Jul; 82():225-32. PubMed ID: 24904969
[TBL] [Abstract][Full Text] [Related]
19. In vivo assessment of intraplaque and endothelial fibrin in ApoE(-/-) mice by molecular MRI.
Makowski MR; Forbes SC; Blume U; Warley A; Jansen CH; Schuster A; Wiethoff AJ; Botnar RM
Atherosclerosis; 2012 May; 222(1):43-9. PubMed ID: 22284956
[TBL] [Abstract][Full Text] [Related]
20. Promising strategies for Gd-based responsive magnetic resonance imaging contrast agents.
Shen C; New EJ
Curr Opin Chem Biol; 2013 Apr; 17(2):158-66. PubMed ID: 23141598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
